skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Selective laser trabeculoplasty reduces mean IOP and IOP variation in normal tension glaucoma patients

Original Research

(1976) Views  (653) Full article downloads

Authors: Mohammed K El Mallah, Molly M Walsh, Sandra S Stinnett, et al

Published Date July 2010 Volume 2010:4 Pages 889 - 893
DOI: http://dx.doi.org/10.2147/OPTH.S11787

Mohammed K El Mallah1, Molly M Walsh2, Sandra S Stinnett2, Sanjay G Asrani2
1Ocala Eye, Ocala, Florida, USA; 2Duke University Eye Center, Durham, North Carolina, USA

Purpose: To evaluate the effect of selective laser trabeculoplasty (SLT) in normal tension glaucoma (NTG) patients.

Patients and methods: A retrospective review was performed of NTG patients who had undergone SLT at the Duke University Eye Center between 12/2002 and 7/2005. For each eye of each patient at pre-laser and post-laser time points, the IOP measurements were summarized by mean, standard deviation, and range. Then for each of these descriptive statistics, the differences between pre-laser and post-laser values were obtained. Statistical analysis was performed using a random effects model. Main outcome measures: difference in mean IOP, standard deviation of IOP, and range of IOP.

Results: Thirty-one eyes of 18 patients were included for analysis. The average of the mean ­pre-operative IOP measurements was 14.3 ± 2.6 mmHg compared to 12.2 ± 1.7 mmHg (P < 0.001) post-operatively. The mean pre-operative standard deviation was 1.9 ± 0.9 mmHg compared to 1.0 ± 0.6 mmHg (P = 0.002) post-operatively while the mean IOP range prior to treatment was 4.5 ± 2.5 mmHg compared to 2.5 ± 1.9 mmHg (P = 0.017) after treatment.

Conclusion: In this pilot study, SLT was found to lower mean IOP and intervisit IOP ­variation in NTG patients. Given the importance of IOP variation and its association with glaucoma ­progression, measurement of IOP variation following treatment with SLT may be considered.

Keywords: SLT, NTG, laser, glaucoma







Readers of this article also read:

Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control: a survey
Low-dose aspirin as treatment for central serous chorioretinopathy
Long-term safety and efficacy of selective laser trabeculoplasty as primary therapy for the treatment of pseudoexfoliation glaucoma compared with primary open-angle glaucoma
Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate
Effect of prior cataract surgery on the long-term outcome of selective laser trabeculoplasty
Predictive factors of success in selective laser trabeculoplasty (SLT) treatment
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection